- Issuer ticker
-
AQST
- Reported as of
-
04 Dec 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
05 Dec 2025, 13:06:06 UTC
Filing notes and source
Key filing fact
Peter E. Boyd filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 05 Dec 2025.
Key facts
- This page summarizes Peter E. Boyd's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Dec 2025, 13:06.
Change
- Previous filing in this sequence was filed on 17 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001739816
Primary reporting owner
Boyd Peter E.
- Relationship
-
Chief People Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AQST
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +20,000
- Change %
- +7.5%
- Price
-
$0.000000
- Shares after
- 288,323
- Date
- 04 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote